SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics

SBC Medical (Nasdaq: SBC) announced a strategic alliance between Medical Corporation Nasukai (operator of Shonan Beauty Clinic) and Daibi Medical Aesthetics in Shanghai to share clinical expertise, operations and safety practices.

Rhea-AI Summary

SBC Medical (Nasdaq: SBC) announced a strategic alliance between Medical Corporation Nasukai (operator of Shonan Beauty Clinic) and Daibi Medical Aesthetics in Shanghai to share clinical expertise, operations and safety practices.

The partnership aims to boost Shonan Beauty Clinic brand recognition in China, support inbound medical tourism to Japan and explore cross-border revenue opportunities; inbound visits rose from ~600 in early 2024 to ~1,700 by end-2025.

Positive

• Inbound customers nearly tripled to ~1,700 by end of 2025
• Alliance links to Daibi’s ~2,200 square-meter Shanghai clinic
• Targets medical tourism market with 23% CAGR (2024–2032) to $62.18B

Negative

• None.

Argus Feb 2 session

+7.42% close to close Open Argus

Details

News Market Reaction – SBC

On Feb 2, the first trading day after this news, SBC closed 7.42% above the previous close.

Data tracked by StockTitan Argus for the Feb 2 session.

Key Figures

Medical tourism CAGR: 23.0% Medical tourism market: USD 62.18 billion Daibi clinic size: 2,200 square meters +5 more

Medical tourism CAGR

23.0%

Global medical tourism market 2024–2032

Medical tourism market

USD 62.18 billion

Projected global market size by 2032

Daibi clinic size

2,200 square meters

Floor space of Daibi Medical Aesthetics in Shanghai

Inbound customers early 2024

approximately 600 customers

Inbound visits to Shonan Beauty Clinic

Inbound customers end 2025

around 1,700 customers

Inbound visits to Shonan Beauty Clinic

Current share price

$4.58

Pre-news market context for SBC

Daily price change

8.27%

Change over prior 24 hours

Today’s volume

42,356 shares

Compared with 20-day average volume of 28,306

Previous Partnership Reports

2 past events · Latest: Jan 07

Same Type 2 events

1. Jan 07

   Strategic partnership

   24h Move

   -0.2%

   Alliance and minority investment with U.S. MedSpa chain OrangeTwist.

2. Nov 14

   Market entry deal

   24h Move

   -1.5%

   Consulting partnership with BLEZ to enter the Thai aesthetic market.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

medical tourism, compound annual growth rate, cagr

3 terms

medical tourism medical

"The alliance comes amid growing global interest in medical tourism, defined as international travel..."

Traveling to another country to get medical care, often because it is cheaper, faster, or offers treatments not available at home. For investors, medical tourism affects demand and pricing for hospitals, clinics, insurers, and travel services much like cross-border shopping shifts where consumers spend money; it can create growth opportunities but also adds regulatory, quality-control, and reputational risks that influence revenues and valuations.

compound annual growth rate financial

"the global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0%..."

The compound annual growth rate (CAGR) shows how much an investment or value has grown, on average, each year over a specific period. It considers the effect of growth that compounds or builds upon itself, similar to how interest accumulates in a savings account. Investors use CAGR to compare different investments’ long-term performance and to understand how steady or consistent their growth has been over time.

cagr financial

"projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032..."

Compound Annual Growth Rate (CAGR) measures the average yearly growth of an investment, revenue, or other metric over a multi-year period as if it had grown at a steady rate each year. Think of it like the constant speed that would take you from the starting value to the ending value over the same time—useful because it smooths out ups and downs and lets investors compare different assets or performance periods on an even footing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan

IRVINE, Calif., Feb. 1, 2026 /PRNewswire/ -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Medical Corporation Nasukai, a Japan-based medical corporation supported by SBC Medical and the operator of Shonan Beauty Clinic, has entered into a strategic business alliance with Daibi Medical Aesthetics, a medical aesthetic clinic based in Shanghai, China. The alliance aims to enhance the quality of services at Daibi Medical Aesthetics by sharing Nasukai's clinical expertise, operational know-how, and customer-centered practices cultivated by its long-standing experience in aesthetic medicine. The collaboration also seeks to strengthen recognition in China of the Shonan Beauty Clinic brand's safety standards and advanced medical technologies.

These efforts aim to deepen SBC Medical's understanding of China's medical environment and customer needs, while supporting increased inbound customer visits to Shonan Beauty Clinic in Japan and exploring long-term revenue opportunities associated with growing cross-border medical demand.

Established in 2021, Daibi Medical Aesthetics subsequently opened its clinic in 2022 in Shanghai's North Bund area. The clinic operates approximately 2,200 square meters of floor space and provides community-based medical aesthetic services. Under the alliance, physicians affiliated with Nasukai will work within Daibi Medical Aesthetics' clinical framework to share knowledge and expertise related to medical safety, clinic operations, and consultation practices. The two parties will also explore opportunities to promote mutual understanding and professional exchange in the field of aesthetic medicine between Japan and China, with specific initiatives being considered in phases.

The alliance comes amid growing global interest in medical tourism, defined as international travel for the purpose of receiving medical services. According to Fortune Business Insights, the global medical tourism market is projected to grow at a compound annual growth rate (CAGR) of 23.0% from 2024 to 2032, reaching approximately USD 62.18 billion by 2032.

As global interest in medical tourism continues to rise, Japanese aesthetic medicine has gained strong recognition, particularly across Asia, for its advanced medical technologies, safety standards, and attentive consultation practices. Reflecting this trend, inbound customer visits to Shonan Beauty Clinic have increased steadily, nearly tripling from approximately 600 customers in early 2024 to around 1,700 customers by the end of 2025.To support this growing demand, Shonan Beauty Clinic has enhanced its inbound medical infrastructure through initiatives such as the development of Chinese-language translation tools and the renewal of its Chinese and English language official websites, providing overseas customers with clear and reliable medical information and a supportive care environment.

Shonan Beauty Clinic (Chinese): https://cn.sbc-beauty.com/
Shonan Beauty Clinic (English): https://en.sbc-beauty.com/

This alliance is expected to further support these efforts by enabling deeper insight into medical practices and customer expectations in China, contributing to a more seamless and consistent customer experience from pre-visit information to post-treatment follow-up, while also supporting improvements in the quality and reliability of aesthetic medical services at the local level.

Through its consulting and management support for medical institutions including Shonan Beauty Clinic, SBC Medical remains committed to building constructive partnerships with local stakeholders, fostering sustainable international medical exchange through medical tourism, and delivering customer-centered medical care that transcends national and regional boundaries.

About Daibi Medical Aesthetics
Location: Room 3301, No. 1158 Dongdaming Road, Hongkou District, Shanghai, China
CEO: Haibo Yu
Business: Provision of medical aesthetic services

About Nasukai
Location: 2F Maruito Ginza Building, 1-3-9 Ginza, Chuo-ku, Tokyo, Japan
Chairman: Keisuke Takeda
Business: Comprehensive medical services spanning specialized medicine, aesthetic medicine, insured medical care, and elective treatments

About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000^® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.

Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Head of Public Relations: E-mail: pr@sbc.or.jp

ICR LLC (US Time)
Bill Zima / Managing Partner E-mail: bill.zima@icrinc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/sbc-medical-supported-medical-corporation-nasukai-forms-strategic-alliance-with-daibi-medical-aesthetics-302674945.html

SOURCE SBC Medical Group Holdings Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SBC (Nasdaq: SBC) alliance with Daibi Medical Aesthetics involve?

It establishes clinical and operational collaboration between Nasukai and Daibi in Shanghai. According to SBC, physicians will share medical-safety practices, consultation methods, and clinic operations to align service quality and support inbound patient coordination.

How might the SBC–Daibi alliance affect inbound visits to Shonan Beauty Clinic (SBC)?

The alliance aims to support increased inbound visits and smoother cross-border care. According to SBC, initiatives include shared practices and improved pre-visit to post-treatment continuity to attract and support overseas patients.

What scale of operations does Daibi Medical Aesthetics have in Shanghai under the alliance?

Daibi operates a roughly 2,200 square-meter clinic in Shanghai’s North Bund area. According to SBC, that facility will host knowledge exchange and physician collaboration under phased initiatives to strengthen local service quality.

How significant is the medical tourism market opportunity cited by SBC for this alliance?

SBC cites a large, fast-growing market: a projected 23% CAGR from 2024–2032 to about $62.18 billion. According to SBC, this underpins long-term cross-border demand and potential revenue opportunities for participating clinics.

What measurable inbound demand growth did Shonan Beauty Clinic report through 2025?

Inbound customer visits increased from about 600 in early 2024 to around 1,700 by end-2025. According to SBC, the clinic also upgraded Chinese-language tools and websites to support overseas patients and clearer information.